Allergy Immunotherapy Market

Industry Outlook

The allergy immunotherapy market had a market value of US$ 1,499.0 million in 2017 and was expected to grow at a CAGR of 10.1% between 2018 and 2026. Allergy immunotherapy helps to prevent or minimize allergic reactions and provides a long-term benefits to patients. This therapy helps to increase immunological tolerance and changes the course of the disease, due to which the demand for immunotherapy is increasing globally.

Market Synopsis

Subcutaneous immunotherapy (SCIT) is a popular treatment for allergic rhinitis and asthma because it provides patients with long-term relief.

SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of an allergic reaction by focusing on the basic mechanisms of immunology. Thus, in 2017, SCIT was identified as the largest allergy immunotherapy type that is preferred and adopted by most physicians. In addition to that, compared with conventional treatment, the cost-effectiveness of SCIT is high, and new molecules under the trial will assist in the overall growth of allergy immunotherapy.

Air pollution has increased due to infrastructural development and industrialization in China and India, specifically assisting the growth of asthma and allergic rhinitis.

The Asia Pacific region is the fastest-growing segment, owing to key driving factors such as rising prevalence and awareness of allergic conditions, as well as increased air pollution in China and India as a result of industrialization and infrastructure development. According to the World Health Organization (WHO), there has been a significant growth in the prevalence of allergic rhinitis in Asia–Pacific within the last decade, which has increased the economic burden. According to experts, the key factors responsible for the sudden growth in allergic rhinitis are the changing environment, improvements in hygiene and reduced infections, and increasing cases of genetic complications.

Historical and Future Period

The allergy immunotherapy market was analyzed considering current market trends for the base year of 2017, and based on future trends, CAGRs were calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on the allergy immunotherapy market provides an in-depth analysis with quantitative and qualitative data points related to the major market dynamics (opportunities, drivers, and restraints) affecting or assisting the market, as well as regional trends and further sub-segmented markets by country. Extensive information on the global allergy immunotherapy market is provided in the report by segmenting the market based on the type of allergy, treatment, and geography. The major objective of publishing this research report is to assist the companies operating in this market in designing and implementing strategies in the allergy immunotherapy market.

This report also covers segments, including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information about the global allergy immunotherapy market. The key market players analyzed in the report are based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Hollister Stier, Leti, WOLW Pharma, Aimmune Therapeutics, ALK-Abello A/S, Stallergenes Greer, Allergopharma, DVB Technologies, Allergy Therapeutics, Biomay AG, HAL Allergy Group, Circassia, and Merck KGaA, among others.

Key questions are answered in this report.

• Which is the trending allergy type in the market and why?
• What are the recent market strategies adopted and implemented by key companies present in the allergy immunotherapy market?
• Which are the most attractive markets (regions and countries) that are prominent and rapidly growing throughout the forecast period in the allergy immunotherapy market?
• Which is the largest and fastest-growing allergy immunotherapy treatment globally?
• Which are the major treatments contributing to the overall growth of allergy immunotherapy in the near future?
• What is the competitive environment in the allergy immunotherapy market, and what are the strategies of major companies in this industry?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global AI Market Portraiture
2.2. Global AI Market, by Type of Allergy, 2017 (US$ Mn)
2.3. Global AI Market, by Type of Treatment, 2017 (US$ Mn)
2.4. Global AI Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Allergy Immunotherapy (AI) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Food Allergy
4.3. Allergic Rhinitis
4.4. Skin Allergy
4.5. Insect-bite Allergy
4.6. Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)

Chapter 5. Global Allergy Immunotherapy (AI) Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Subcutaneous Immunotherapy (SCIT)
5.3. Sublingual Immunotherapy (SLIT)

Chapter 6. Global Allergy Immunotherapy (AI) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America AI Market Analysis, 2016 – 2026
6.2.1. North America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.2.2. North America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.2.3. North America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AI Market Analysis, 2016 – 2026
6.3.1. Europe AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.3.2. Europe AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.3.3. Europe AI Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific AI Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America AI Market Analysis, 2016 – 2026
6.5.1. Latin America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.5.2. Latin America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.5.3. Latin America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) AI Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.6.3. MEA AI Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. ALK-Abello A/S
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. HAL Allergy Group
7.3. Circassia
7.4. Aimmune Therapeutics
7.5. Merck KGaA
7.6. Anergis
7.7. Biomay AG
7.8. Stallergenes Greer
7.9. DBV Technologies
7.10. Allergy Therapeutics

List of Figures

FIG. 1 : Allergy Immunotherapy (AI): Market Segmentation
FIG. 2 : Global AI Market Share, by Type of Allergy, 2017 (US$ Mn)
FIG. 3 : Global AI Market Share, by Type of Treatment, 2017 (US$ Mn)
FIG. 4 : Global AI Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 : Attractive Investment Proposition, by Geography, 2017
FIG. 6 : Market Competition Landscape, by Key Players, 2017
FIG. 7 : Global Food AI Market, 2016 – 2026 (US$ Mn)
FIG. 8 : Global Allergic Rhinitis Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Skin AI Market, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Insect-bite AI Market, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Other Allergies Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Subcutaneous Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Sublingual Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. AI Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada AI Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. AI Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany AI Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest Of Europe AI Market, 2016 – 2026 (US$ Mn)
FIG. 19 : Japan AI Market, 2016 – 2026 (US$ Mn)
FIG. 20 : China AI Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest Of Asia Pacific AI Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil AI Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico AI Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest Of Latin America AI Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC AI Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest Of Middle East And Africa AI Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 : Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 2 : Global AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 3 : North America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 4 : North America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 5 : North America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 8 : Europe AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 10 : Asia Pacific AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 11 : Asia Pacific AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Latin America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 13 : Latin America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 14 : Latin America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 : Middle East & Africa AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 16 : Middle East & Africa AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 17 : Middle East And Africa AI Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 : ALK-Abello A/S: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 : Stallergenes Greer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 : DBV Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 : Allergy Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 : HAL Allergy Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 : Circassia: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 : Aimmune Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 : Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 : Anergis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 : Biomay AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)